CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
Banner4 Banner2 Banner3
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Nonalcoholic fatty liver disease linked to procoagulant imbalance
04-02-2014
Costs to public of $84,000 hep C drug 'outrageous' - Kaiser
04-02-2014
Gilead says has discounted hepatitis C drug for some health plans
03-31-2014
Glycerol phenylbutyrate improves hepatic encephalopathy outcomes
03-28-2014
View Complete News Library
 
 
June 4-7
20th Annual International Congress Of The International Liver Transplantation Society (ILTS)
London, UK
June 6-7
GALA (GI and Liver Association of the Americas) Conference
Dallas, Texas
June 9-12
47th Annual Meeting- The European Society For Pediatric Gastroenterolgy, Hepatology & Nutrition (ESPGHAN)
Jerusalem, Israel
July 26-31
American Transplant Congress
San Francisco, California
View all Congresses
 
 
 
 
  Line  
  Featured Abstracts          
 
Impact of Provider Type on Hepatitis C Outcomes With Boceprevir-based and Telaprevir-based Regimens
 
Hepatitis C virus: a silent killer relevant to dentistry
 
Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 HCV in interferon ineligible/intolerant individuals
 
Boceprevir In Liver Transplant Recipients
 
Second wave Anti-HCV Protease Inhibitors: Too little too late?
 
The Effect of Mild to Moderate Renal Impairment on the Pharmacokinetics of the Nucleoside Analog Hepatitis C Virus Polymerase Inhibitor Mericitabine
 
 
Characterization of Chronic Hepatitis B Cases Among Foreign-Born Persons in Six Population-Based Surveillance Sites, United States 2001-2010
 
Distinct Seromarkers Predict Different Milestones of Chronic Hepatitis B Progression
 
Prevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007
 
Prevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007
 
Sodium benzoate for treatment of hepatic encephalopathy
 
Survival in infection-related acute-on-chronic liver failure is defined by extra-hepatic organ failures
 
 
Cerebral Hemodynamics In Cirrhotic Patients With Hepatic Encephalopathy
 
Management of hyponatremia in clinical hepatology practice
 
Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model
 
Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis
 
Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
 
Improved Survival Outcomes in Patients with Nonalcoholic Steatohepatitis and Alcoholic Liver Disease Following Liver Transplantation: An Analysis of 2002-2012 UNOS Data
 
 
          View All Abstracts  
  Line  
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.